Neonatology

PubMed Free Full Text

Inborn errors of metabolism

Australia

• Australian Journal of General Practice
  • Universal screening for familial hypercholesterolaemia in newborns: Time for general practice to contribute [2023]

Austria

• Journal of Inherited Metabolic Disease
  • 100 years of inherited metabolic disorders in Austria-A national registry of minimal birth prevalence, diagnosis, and clinical outcome of inborn errors of metabolism in Austria between 1921 and 2021 [2022]

Brazil

• Arquivos de Neuro-Psiquiatria
  • Neuropsychological and quality of life outcomes in PKU patients: expert recommendations of assessment tools in Brazil [2023]

China

• BMJ Open
  • Phenylketonuria incidence in China between 2013 and 2017 based on data from the Chinese newborn screening information system: a descriptive study [2019]

• Frontiers in Molecular Biosciences
  • Reference Standards for Newborn Screening of Metabolic Disorders by Tandem Mass Spectrometry: A Nationwide Study on Millions of Chinese Neonatal Populations [2021]

• Orphanet Journal of Rare Diseases
  • Chinese genetic variation database of inborn errors of metabolism: a systematic review of published variants in 13 genes [2023]
  • China nationwide landscape of 16 types inherited metabolic disorders: a retrospective analysis on 372,255 clinical cases [2023]

Europe

• Orphanet Journal of Rare Diseases
  • The European reference network for metabolic diseases (MetabERN) clinical pathway recommendations for Pompe disease (acid maltase deficiency, glycogen storage disease type II) [2024]
  • Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia [2014]
  • Suggested Guidelines for the Diagnosis and Management of Urea Cycle Disorders [2012]

Europe, United States

• Orphanet Journal of Rare Diseases
  • Similarities and differences in key diagnosis, treatment, and management approaches for PAH deficiency in the United States and Europe [2020]

France

• Haute Autorité de Santé
  • Recommendations for the expansion of newborn screening to MCAD deficiency [2011]

Hong Kong

• Hong Kong Medical Journal
  • The first pilot study of expanded newborn screening for inborn errors of metabolism and survey of related knowledge and opinions of health care professionals in Hong Kong [2018]

International

• Cells
  • Newborn Screening: Review of its Impact for Cystinosis [2022]

• Clinical and Experimental Pediatrics
  • Global prevalence of classic phenylketonuria based on Neonatal Screening Program Data: systematic review and meta-analysis [2020]

• International Journal of Neonatal Screening
  • Newborn Screening for Lysosomal Storage Diseases: A Concise Review of the Literature on Screening Methods, Therapeutic Possibilities and Regional Programs [2017]

• Journal of Inherited Metabolic Disease
  • Guidelines for the diagnosis and management of cystathionine beta-synthase deficiency [2017]
  • Newborn screening for homocystinurias and methylation disorders: systematic review and proposed guidelines [2015]

• Molecular Genetics and Metabolism
  • The impact of COVID-19 pandemic on the diagnosis and management of inborn errors of metabolism: A global perspective [2020]
  • Nutrition management guideline for maple syrup urine disease: An evidence- and consensus-based approach [2014]

• Neonatology
  • Inborn Errors of Metabolism That Cause Sudden Infant Death: A Systematic Review with Implications for Population Neonatal Screening Programmes [2016]

• Neurology
  • International Recommendations for the Diagnosis and Management of Patients With Adrenoleukodystrophy: A Consensus-Based Approach [2022]

• Nutrients
  • The Importance of Neonatal Screening for Galactosemia [2022]

• Orphanet Journal of Rare Diseases
  • Consensus guideline for the diagnosis and treatment of tetrahydrobiopterin (BH 4 ) deficiencies [2020]

Iran

• BMC Health Services Research
  • A policy analysis of the national phenylketonuria screening program in Iran [2021]

• BMC Pediatrics
  • Phenylketonuria screening in Iranian newborns: a systematic review and meta-analysis [2020]

• Journal of Research in Medical Sciences
  • Newborn Screening for inherited metabolic disorders; news and views [2013]

Japan

• International Journal of Neonatal Screening
  • Current Perspectives on Neonatal Screening for Propionic Acidemia in Japan: An Unexpectedly High Incidence of Patients with Mild Disease Caused by a Common PCCB Variant [2021]
  • Advanced Diagnostic System and Introduction of Newborn Screening of Adrenoleukodystrophy and Peroxisomal Disorders in Japan [2021]

• Orphanet Journal of Rare Diseases
  • Current status of newborn screening for Pompe disease in Japan [2021]

Kuwait

• International Journal of Neonatal Screening
  • Early Diagnosis of Classic Homocystinuria in Kuwait through Newborn Screening: A 6-Year Experience [2021]

Latin America

• International Journal of Neonatal Screening
  • Neonatal Screening for MPS Disorders in Latin America: A Survey of Pilot Initiatives [2020]

• Nutrients
  • Current Practices and Challenges in the Diagnosis and Management of PKU in Latin America: A Multicenter Survey [2021]

Macedonia

• Orphanet Journal of Rare Diseases
  • Phenylketonuria screening in the Republic of Macedonia [2016]

Middle East

• Therapeutics and Clinical Risk Management
  • Guidelines for acute management of hyperammonemia in the Middle East region [2016]

Netherlands

• Frontiers in Cell and Developmental Biology
  • Adrenoleukodystrophy Newborn Screening in the Netherlands (SCAN Study): The X-Factor [2020]

• Human Mutation
  • Update of the Pompe variant database for the prediction of clinical phenotypes: Novel disease-associated variants, common sequence variants, and results from newborn screening [2021]

• JIMD Reports
  • Evaluation of 11 years of newborn screening for maple syrup urine disease in the Netherlands and a systematic review of the literature: Strategies for optimization [2020]

• Journal of Inherited Metabolic Disease
  • Sex-specific newborn screening for X-linked adrenoleukodystrophy [2023]

New Zealand

• National Screening Unit
  • Newborn Metabolic Screening Programme

Poland

• Genes
  • Molecular Background and Disease Prevalence of Biotinidase Deficiency in a Polish Population-Data Based on the National Newborn Screening Programme [2022]

Saudi Arabia

• Annals of Saudi Medicine
  • Cut-off values in newborn screening for inborn errors of metabolism in Saudi Arabia [2022]

Slovenia

• Genes
  • Optimizing the Phenylalanine Cut-Off Value in a Newborn Screening Program [2022]

South-Eastern Europe

• Orphanet Journal of Rare Diseases
  • Phenylketonuria screening and management in southeastern Europe – survey results from 11 countries [2015]

Taiwan

• Diagnostics
  • Nationwide Newborn Screening Program for Mucopolysaccharidoses in Taiwan and an Update of the “Gold Standard” Criteria Required to Make a Confirmatory Diagnosis [2021]

• Journal of Pediatrics
  • Outcome of later-onset Pompe disease identified through newborn screening [2022]

Thailand

• PLoS ONE
  • An Economic Evaluation of Neonatal Screening for Inborn Errors of Metabolism Using Tandem Mass Spectrometry in Thailand [2015]

United Arab Emirates

• JIMD Reports
  • Inborn Errors of Metabolism in the United Arab Emirates: Disorders Detected by Newborn Screening (2011–2014) [2015]

United Kingdom

• International Journal of Neonatal Screening
  • The Cost-Effectiveness of Expanding the UK Newborn Bloodspot Screening Programme to Include Five Additional Inborn Errors of Metabolism [2020]

• National Institute for Health and Care Excellence
  • Sebelipase alfa for treating Wolman disease [2024]

• NHS England
  • Clinical commissioning policy: Subcutaneous copper histidinate injections for presymptomatic neonates with classical Menkes disease [2023]

• Public Health England
  • Newborn blood spot screening: laboratory guide for IMDs

• UK National Screening Committee
  • Tyrosinaemia
  • PKU
  • Organic acid oxidation disorders
  • MSUD
  • MPS I
  • MCADD
  • LCHADD
  • IVA
  • HCU
  • Gaucher disease
  • Galactosaemia
  • GA1
  • Biotinidase deficiency
  • Amino acid metabolism disorders
  • ALD

United States

• American College of Medical Genetics and Genomics
  • Biomarker testing for lysosomal diseases: A technical standard of the American College of Medical Genetics and Genomics (ACMG) [2024]
  • Measurement of lysosomal enzyme activities: A technical standard of the American College of Medical Genetics and Genomics (ACMG) [2022]
  • Laboratory analysis of acylcarnitines, 2020 update: a technical standard of the American College of Medical Genetics and Genomics (ACMG) [2021]
  • Laboratory diagnosis of disorders of peroxisomal biogenesis and function: a technical standard of the American College of Medical Genetics and Genomics (ACMG) [2020]
  • Laboratory diagnosis of galactosemia: a technical standard and guideline of the American College of Medical Genetics and Genomics (ACMG) [2018]
  • Laboratory diagnosis of biotinidase deficiency, 2017 update: a technical standard and guideline of the American College of Medical Genetics and Genomics [2017]
  • Lysosomal storage diseases: diagnostic confirmation and management of presymptomatic individuals [2011]

• Centers for Disease Control and Prevention
  • Good Laboratory Practices for Biochemical Genetic Testing and Newborn Screening for Inherited Metabolic Disorders [2012]

• Genetics in Medicine
  • Newborn screening 50 years later: access issues faced by adults with PKU [2013]

• International Journal of Neonatal Screening
  • Lessons Learned from Pompe Disease Newborn Screening and Follow-up [2020]
  • Expanding Newborn Screening for Pompe Disease in the United States: The NewSTEPs New Disorders Implementation Project, a Resource for New Disorder Implementation [2020]
  • Current Practices for U.S. Newborn Screening of Pompe Disease and MPSI [2020]
  • Newborn Screening for X-Linked Adrenoleukodystrophy [2016]

• Journal of Inherited Metabolic Disease
  • MRI surveillance of boys with X-linked adrenoleukodystrophy identified by newborn screening: Meta-analysis and consensus guidelines [2021]

• Molecular Genetics and Metabolism
  • Screening, patient identification, evaluation, and treatment in patients with Gaucher disease: Results from a Delphi consensus [2022]

• Molecular Genetics and Metabolism Reports
  • Strategies to engage lost to follow-up patients with phenylketonuria in the United States: Best practice recommendations [2020]

• Orphanet Journal of Rare Diseases
  • Consensus guidelines for newborn screening, diagnosis and treatment of infantile Krabbe disease [2018]

• Pediatric Endocrine Society
  • Adrenoleukodystrophy: Guidance for Adrenal Surveillance in Males Identified by Newborn Screen [2018]

{Related topics}

• Topic
  • Newborn
  • Neonatal screening